Showing 1 - 5 results of 5 for search 'Irene Urbino', query time: 0.03s Refine Results
  1. 1
    ECULIZUMAB DOSE ADJUSTMENTS DURING PREGNANCIES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A SINGLE CENTER EXPERIENCE.

    ECULIZUMAB DOSE ADJUSTMENTS DURING PREGNANCIES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A SINGLE CENTER EXPERIENCE. by Semra Aydin, Valentina Giai, Stefano D'ardia, Giorgia Iovino, Chiara Frairia, Irene Urbino, Marco Cerrano, Eloise Beggiato, Ernesta Audisio

    Published 2022-10-01
    Get full text
    Article
  2. 2
    P678: EARLY WARNING RESPONSES IN CML PATIENTS: A REAL-LIFE TURIN EXPERIENCE

    P678: EARLY WARNING RESPONSES IN CML PATIENTS: A REAL-LIFE TURIN EXPERIENCE by Valentina Giai, Matteo Bisio, Tiziana Rosso, Irene Urbino, Chiara Frairia, Matteo Olivi, Giuseppe Lanzarone, Mattia D’agostino, Eloise Beggiato, Stefano D’ ardia, Ernesta Audisio, Marco Cerrano, Dario Ferrero, Patrizia Pregno, Roberto Freilone

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study

    Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study by Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio

    Published 2023-02-01
    Get full text
    Article
  4. 4
    PB2057: THE COMBINATION OF ANTI-COMPLEMENT THERAPY AND CYCLOSPORINE +/- ELTROMBOPAG IN PNH IS EFFECTIVE AND SAFE: A REAL-LIFE OBSERVATIONAL STUDY.

    PB2057: THE COMBINATION OF ANTI-COMPLEMENT THERAPY AND CYCLOSPORINE +/- ELTROMBOPAG IN PNH IS EFFECTIVE AND SAFE: A REAL-LIFE OBSERVATIONAL STUDY. by Federica Catania, Chiara Frairia, Matteo Olivi, Moreno Festuccia, Davide Rapezzi, Barbara Nicolino, Giulia Arrigo, Eleonora Boscaro, Federica DI Biase, Marco Cerrano, Irene Urbino, Eloise Beggiato, Giuseppe Lanzarone, Chiara Maria Dellacasa, Alessandro Busca, Dario Ferrero, Stefano D’ardia, Ernesta Audisio, Roberto Freilone, Valentina Giai

    Published 2023-08-01
    Get full text
    Article
  5. 5
    P553: PRELIMINARY RESULTS OF MRD ANALYSIS OF AML1718, A PHASE 2 OPEN-LABEL STUDY OF VENETOCLAX, FLUDARABINE, IDARUBICIN AND CYTARABINE (V-FLAI) IN THE INDUCTION THERAPY OF NON LOW-RISK AML

    P553: PRELIMINARY RESULTS OF MRD ANALYSIS OF AML1718, A PHASE 2 OPEN-LABEL STUDY OF VENETOCLAX, FLUDARABINE, IDARUBICIN AND CYTARABINE (V-FLAI) IN THE INDUCTION THERAPY OF NON LOW-... by Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paoloni, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara DI Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adrianno Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto Massimo Lemoli

    Published 2023-08-01
    Get full text
    Article

Search Tools: